Explore small cap ideas before they hit the headlines.
Explore small cap ideas before they hit the headlines.
Good to see we're climbing now. If only we can maintain the steady march to 20..
I need you guys in the back to get out and give us a little push over this eleven dollar hill. Com'on put your back into it.
I've got dead money parked here waiting and I'm tired. Maybe later.
Something cooking? All kinds of possibilities....
Pitiful... Did better on my bio stocks
Biden WH to Restart Permitting Major Offshore Wind Project.
The U.S. Bureau of Ocean Energy Management (BOEM) said in a statement it would resume an environmental review of the Vineyard Wind project as part of the administration's broad plan to speed renewable energy development on federal lands and waters.
https://www.newsmax.com/politics/vineyard-wind-turbines-energy/2021/02/03/id/1008555/
Vineyard Wind Selects GE Renewable Energy As Preferred Turbine Supplier For America's First Utility Scale Offshore Wind Project
https://www.vineyardwind.com/press-releases/2020/12/1/vineyard-wind-selects-ge-renewable-energy-as-preferred-turbine-supplier
On Monday, Obin said GE’s 3% year-over-year drop in orders in the fourth quarter was also a pleasant surprise given orders dropped 28% in the previous quarter.
Heading into the new year, GE CEO Larry Culp highlighted his company's strong cash performance, predicting that 2021 will see GE produce a further $2.5 billion to $4.5 billion in positive free cash flow. If BofA is right about the future belonging to green energy, GE's finally looking like it's in a good financial position to capitalize on those opportunities.
Bank of America analyst Andrew Obin reiterated his Buy rating for GE and raised his price target from $13 to $14.
(Clips from the latest news headlines)
Well I can see I'm not gonna be a millionaire this quarter, I'll settle for thousandaire for now. After watching Culp in action over the last three quarters while trudging thru this Covid shitshow I am pretty well convinced where I'll be $ in another year or two. I will sleep well tonight and for as long as Culp is in place. He's not gonna f'up his huge performance bonus and I'm sticking to GE like glue. Got in over my head and against my best judgement at $6.30 and I'll stay until $60.30 two years from now.
You guys in the back need to row faster, let's get thru this 12 mark
Maybe we'll get a Gamestop day or two, hee hee Now that would be interesting.
From the "G" site: >>>>>If the implied volatility is high, the market thinks the stock has potential for large price swings in either direction, just as low IV implies the stock will not move as much by option expiration. ... Implied volatility helps you gauge how much of an impact NEWS may have on the underlying stock.<<<<<
CYTR a possible MA low float worth a look
Got ya, It all became a little clearer, after I read the eighth line in the 8k a couple of times. >>>employment is terminated without “cause” following a “change in control” (as defined in his employment agreement))<<<<
I say tomato and some say potato, either way it is a pittance and CYTR has a bushel full of CA$H to pay it.
Mr. Caloz has entered into a new employment agreement which would tend to predict another years employment with CYTR.
>>>On January 5, 2021, CytRx Corporation (“the Company”) entered into a new Employment Agreement, effective January 1, 2021, with John Y. Caloz, under which we agree to continue to employ Mr. Caloz as our Chief Financial Officer through December 31, 2021<<<
I need a bigger rake to scoop up all this cash trade....
"Doing what we do best" AAl flying again
Still crickets here....
New York Times blowing the trumpet for GE... Wow, who would have imagined. [color=red]"A Monster Wind Turbine Is Upending an Industry"
https://www.nytimes.com/2021/01/01/business/GE-wind-turbine.html
For the newly curious about CYTR:
CytRx Corporation (OTCQB: CYTR) is a biopharmaceutical company with expertise in discovering and developing new therapeutics principally to treat patients with cancer and neurodegenerative diseases. CytRx's most advanced drug conjugate, aldoxorubicin, is an improved version of the widely used anti-cancer drug doxorubicin and has been outlicensed to ImmunityBio, Inc. In addition, CytRx's other drug candidate, arimoclomol, was sold to Orphazyme (Nasdaq: ORPH) Orphazyme A/S (Nasdaq Copenhagen exchange: ORPHA.CO) in exchange for milestone payments and royalties. Orphazyme is testing arimoclomol in four indications including amyotrophic lateral sclerosis (ALS), Niemann-Pick disease Type C (NPC), Gaucher disease and sporadic Inclusion Body Myositis (sIBM). CytRx Corporation’s website is www.cytrx.com.
Good enough for Harry Reid it's good enough for me. I'm in for the 50's
News item listed above: "Notes that are accepted in the Offers will be purchased, retired and cancelled by GE or its subsidiaries, as applicable, and will no longer remain outstanding obligations of GE or any of its subsidiaries."
We’ll have a bill produced for the American people tomorrow
(12/14/20)-- $908 billion.”
https://www.foxnews.com/politics/manchin-bipartisan-coronavirus-bill-fox-news-sunday
Today’s announcement brings the entire scope of the SEC investigation of GE to a close. "The SEC’s order makes no allegation that prior period financial statements were misstated. This settlement does not require corrections or restatements of GE’s previously reported financial statements, and GE stands behind its financial reporting."
https://www.marketwatch.com/story/general-electric-agrees-to-pay-200-million-fine-for-misleading-investors-sec-says-11607552028?siteid=yhoof2
I'm in with Culp. He's going full guns for his big bonus payout and I'm sticking like glue to my GE shares for my quadruple from $6.00. See ya'll at $24.
I've been in AM since Robinhood gave me one free share for opening my second trading account there. I like it just fine and bought a bucket full for both the dividend and the future triple stock price.
Vineyard Wind pauses U.S. permitting over switch to GE turbines
Vestas out (OTCMKTS: VWDRY) GE in...
https://www.reuters.com/article/us-vineyard-wind-ge-offshore-wind-farm/vineyard-wind-picks-ge-turbines-for-massachusetts-offshore-wind-farm-idUSKBN28C2NR
"rapid re-rating" of GE's stock, geez it's easy to be a stock analyst.
Throw some stupid low predictions out there and change them upward as we go. Piece of cake.
Head fake, Gotcha!!
$12.00 before year end....
Uhhhh yeah, I think I mentioned this awhile ago.
GE Stock Is Jumping. Its Cash Pile Is Holding Up, Even in a Tough Year. -- Barrons.com
11:45 AM ET 11/13/20 | Dow Jones
By Al Root
General Electric stock got a boost on Friday after Barclays analyst Julian Mitchell hiked his price target for the shares. The underlying reason for the analyst's move is good news for shareholders, too: GE's balance sheet is in better shape as the global economy improves and as the company's business mix changes.
GE stock jumped 3.1% in recent trading Friday, while the S&P 500 edged up 0.7%.
Mitchell qualifies as a General Electric (ticker: GE) bull. He rates shares Buy and boosted his price target to $11 from $9 Friday morning. The change comes after he hosted GE CFO Carolina Dybeck Happe at a virtual event for Barclays clients.
Mitchell came away from the event believing new management -- including CEO Larry Culp and Dybeck Happe -- have a handle on debt challenges accumulated by past management regimes. "We think the [free cash flow] performance and the state of the balance sheet suggest that even if Covid-19 headwinds persist, the downside floor for GE's share price should be higher," wrote Mitchell.
Analysts expect GE's industrial businesses to burn through roughly $1 billion in the pandemic-affected 2020. Mitchell projects the company will end 2020 with about $25 billion of cash available to its industrial businesses -- cash which can be used to repay debt and restructure businesses.
Mitchell also expects cash flow to improve, easing pressure on the balance sheet in coming years. He projects GE's free cash flow from its industrial businesses will hit $6 billion in 2022. GE's gas power division has made progress, according to the analyst, and aviation free cash flow should rebound from pandemic lows.
GE's renewable energy business, which generates about $15 to $17 billion in sales each year, is also making progress. On Thursday, the company said its Haliade-X wind turbine -- which GE claims is the most powerful offshore wind turbine in the world -- was certified by DNV GL, the largest independent certification body in the world. "This certification provides independent verification that the new turbines will operate safely, reliably, and according to design specifications," said a GE spokesperson in an emailed statement. "This is a key step as it gives customers the ability to obtain financing to purchase the turbines."
But GE's largest business, commercial aviation, still faces headwinds. Commercial aviation demand has been decimated by pandemic. Air travel in the U.S. is down roughly 75% year over year since the beginning of March.
GE stock is down about 20% year to date, worse than comparable returns of the S&P 500 and Dow Jones Industrial Average. But things are looking up for investors more recently. GE shares have risen about 35% over the past month. Positive Covid-19 vaccine news from Pfizer (PFE) boosted all stocks linked to commercial aerospace.
Wound up like a two dollar watch and this thing is gonna blow to the upside about a buck or two. Very soon!!!!
I told ya so too. >>>Given the Wells notice’s expected low impact, GE’s fair value remains unchanged at $16.50 — making a 150% jump likely. Its strong jet engine and medical imaging franchise looks set to recover quickly in 2021.<<<
https://investorplace.com/2020/10/3-reasons-why-ge-stock-will-be-an-i-told-you-so-winner/
Cramer agrees with me on a GE buy
https://www.cnbc.com/2020/10/12/jim-cramer-ford-and-ge-are-headed-back-to-the-double-digits.html
It is my opinion that the short interests are packing their bags and beginning their departure for greener pastures.